Skip to main content
. 2015 Apr 1;5(4):e006874. doi: 10.1136/bmjopen-2014-006874

Figure 1.

Figure 1

Proportion of unadjusted total mean costs per patient prerandomisation (ie baseline) and at 6 months follow-up, by each main cost component and study arm.